US Stock MarketDetailed Quotes

VCYT Veracyte

Watchlist
  • 41.110
  • +1.520+3.84%
Close Feb 14 16:00 ET
  • 41.110
  • 0.0000.00%
Post 20:01 ET
3.19BMarket Cap-316.23P/E (TTM)

About Veracyte Company

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Company Profile

SymbolVCYT
Company NameVeracyte
Listing DateOct 30, 2013
Issue Price13.00
Founded2006
CEOMr. Marc A. Stapley
MarketNASDAQ
Employees815
Fiscal Year Ends12-31
Address6000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-243-6300

Company Executives

  • Name
  • Position
  • Salary
  • Marc A. Stapley
  • Chief Executive Officer and Director
  • 7.18M
  • Dr. John Leite
  • Chief Commercial Officer, CLIA
  • 1.92M
  • Annie McGuire
  • General Counsel and Chief People Officer
  • 2.48M
  • Dr. Phillip G. Febbo, M.D.
  • Chief Scientific and Chief Medical Officer
  • 3.79M
  • Jonathan Wygant
  • Chief Accounting Officer
  • --
  • Rebecca Chambers
  • Chief Financial Officer
  • 2.78M
  • Dr. Robert S. Epstein, M.D.,M.S.
  • Chairman of the Board
  • 337.98K
  • Dr. Tom Miller, PhD
  • Director
  • --
  • Brent Shafer
  • Director
  • --
  • Muna Bhanji, Ph.
  • Independent Director
  • 299.98K
  • Karin Eastham
  • Independent Director
  • 314.98K
  • Dr. Eliav Barr, M.D.
  • Independent Director
  • 294.98K
  • Evan Jones
  • Independent Director
  • 314.98K
  • Jens Holstein
  • Independent Director
  • 327.47K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More